Variable | |
---|---|
Clinical characteristics | |
Age, years | 51±14 |
Male gender, n (%) | 74 (73) |
Body mass index, kg/m2 | 28±5 |
Systolic blood pressure, mm Hg | 116±20 |
Diastolic blood pressure, mm Hg | 71±12 |
Heart rate, bpm | 75±16 |
Atrial fibrillation, n (%) | 18 (18) |
NYHA class (I/II/III/IV) | 15/61/20/6 |
Medical history | |
Smokers, n (%) | 24 (24) |
History of hypertension, n (%) | 18 (18) |
Diabetes mellitus prior to the development of heart failure, n (%) | 4 (4) |
Duration of symptoms, months | 7 (3–16) |
NYHA class at peak symptom severity (I/II/III/IV) | 4/15/25/58 |
ECG | |
QRS-duration, ms | 110 (99–134) |
Left bundle branch block, n (%) | 21 (21) |
Laboratory values | |
Haemoglobin, g/dL | 14.4±1.5 |
Creatinine, pmol/L | 86±21 |
N-terminal pro-B-type natriuretic peptide, pg/mL | 1332 (584–2903) |
Echocardiography | |
Left ventricular ejection fraction, % | 26±10 |
Left ventricular end diastolic diameter, cm | 7.1±0.8 |
Left ventricular end diastolic internal volume, mL | 267 (216–328) |
Cardiac output, L/min | 4.9±1.4 |
Cardiac MRI (88 patients) | |
Left ventricular ejection fraction, % | 28±11 |
Left ventricular end diastolic internal volume, mL | 273 (214–356) |
Left ventricular myocardial volume, mL | 212±62 |
Gadolinium late enhancement, n (%) | 29 (35) |
Exercise testing (96 patients) | |
Maximum work load, W | 133±56 |
Peak heart rate, bpm | 151±25 |
Peak oxygen uptake, mL/kg/min | 19.7±7 |
Peak oxygen uptake as percentage of expected value, % | 69±22 |
Right-sided cardiac catheterisation (97 patients) | |
Right atrial pressure, mm Hg | 6 (4–10) |
Mean pulmonary artery pressure, mm Hg | 24±10 |
Pulmonary capillary wedge pressure, mm Hg | 15±8 |
Cardiac output, L/min | 4.9±1.5 |
24 h ECG (89 patients) | |
Average heart rate, bpm | 76±13 |
Minimum heart rate, bpm | 49±10 |
Maximum heart rate, bpm | 142±28 |
Ventricular tachycardia, n (%) | 25 (28) |
Values are presented as mean±SD or median (IQR) as appropriate.